Results 121 to 130 of about 9,311 (239)

Secondary primary tumors following iodine-125 low-dose-rate brachytherapy for localized prostate cancer. [PDF]

open access: yesInt J Clin Oncol
Niwa K   +11 more
europepmc   +1 more source

Designing chiral organic small molecules for circularly polarized light detection via group theory

open access: yesInfoMat, Volume 8, Issue 8, August 2026.
The chiral point group determines the arrangement of the μ‐m of chiral organic small molecules, thereby influencing their chiral photoelectric properties. In particular, chiral molecules with the D2 point group can effectively align the μ‐m to be either 0° or 180°, an effective strategy for high‐performance circularly polarized light photodetectors ...
Zhenping Li   +10 more
wiley   +1 more source

Understanding Mass Spectrometry: From Ion Generation to Spectral Interpretation

open access: yesJournal of Mass Spectrometry, Volume 61, Issue 8, August 2026.
ABSTRACT This tutorial provides a structured introduction to mass spectrometry (MS), with particular emphasis on electrospray ionization (ESI)–based measurements. It is intended to support researchers from chemistry and related disciplines in developing a coherent understanding of MS principles, instrumentation, and data interpretation.
Arnold Steckel   +2 more
wiley   +1 more source

Spatial Dosimetric-Based Prediction of Long-Term Urinary Toxicity After Permanent Prostate Brachytherapy. [PDF]

open access: yesCancers (Basel)
Ma C   +7 more
europepmc   +1 more source

A multidisciplinary experimental and methodological investigation of electron and proton minibeams in the framework of the INFN MIRO project

open access: yesMedical Physics, Volume 53, Issue 8, August 2026.
Abstract Background The clinical translation of Minibeam RT (MBRT) has recently started thanks to the first human treatments recently performed. However, despite experimental evidence, the impact of the dose distribution parameters involved on the magnitude of the effect itself and the underlying radiobiological mechanisms are still only partially ...
Francesco Romano   +89 more
wiley   +1 more source

Lighting up FLASH and beyond: TLD response across four orders of magnitude in proton dose rate

open access: yesMedical Physics, Volume 53, Issue 8, August 2026.
ABSTRACT Background Thermoluminescent dosimeters (TLDs) are widely used for proton therapy dosimetry and remote audits. Yet their response under pulsed delivery and the ultrahigh dose rates relevant to proton FLASH remains incompletely characterized.
Fada Guan   +10 more
wiley   +1 more source

Long-Term Outcomes of Low-Dose-Rate Brachytherapy in Localized Prostate Cancer: A 17-Year Retrospective Analysis of a Single-Center Portuguese Cohort. [PDF]

open access: yesJ Clin Med
Rabaça C   +9 more
europepmc   +1 more source

Feasibility of convection‐enhanced delivery of unlabeled 225Ac for glioblastoma: Transport, dosimetry, and clonogenic survival modeling

open access: yesMedical Physics, Volume 53, Issue 8, August 2026.
Abstract Background Glioblastoma (GB) is an aggressive primary brain tumor with local recurrence rates exceeding 90% and a five‐year survival rate of approximately 5%. Standard treatments such as surgical resection, external beam radiotherapy (EBRT), and chemotherapy often leave residual tumor cells that are resistant to therapy.
Maram El Sabri   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy